Seçil Çaban

ORCID: 0000-0002-3189-2377
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nanoparticle-Based Drug Delivery
  • Advanced Drug Delivery Systems
  • RNA Interference and Gene Delivery
  • Spinal Cord Injury Research
  • Barrier Structure and Function Studies
  • Advanced biosensing and bioanalysis techniques
  • Cancer Treatment and Pharmacology
  • Membrane-based Ion Separation Techniques
  • Supramolecular Self-Assembly in Materials
  • Nicotinic Acetylcholine Receptors Study
  • Graphene and Nanomaterials Applications
  • Cultural and Sociopolitical Studies
  • Dendrimers and Hyperbranched Polymers
  • Drug Solubulity and Delivery Systems
  • Cell death mechanisms and regulation
  • Nanoplatforms for cancer theranostics
  • biodegradable polymer synthesis and properties
  • Drug Transport and Resistance Mechanisms
  • Adenosine and Purinergic Signaling
  • Protein Hydrolysis and Bioactive Peptides
  • Trace Elements in Health
  • Bone and Joint Diseases

Hacettepe University
2012-2020

Ministry of Health
2019

Pharmaceutical Biotechnology (Czechia)
2009

Caspases play an important role as mediators of cell death in acute and chronic neurological disorders. Although peptide inhibitors caspases provide neuroprotection, they have to be administered intracerebroventricularly because cannot cross the blood–brain barrier (BBB). Herein, we present a nanocarrier system that can transfer chitosan nanospheres loaded with N -benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethyl ketone (Z-DEVD-FMK), relatively specific caspase-3 inhibitor,...

10.1523/jneurosci.4246-09.2009 article EN cc-by-nc-sa Journal of Neuroscience 2009-11-04

Although growth factors and anti-apoptotic peptides have been shown to be neuroprotective in stroke models, translation of these experimental findings clinic is hampered by limited penetration the brain. Here, we show that a large peptide like basic fibroblast factor (bFGF) small inhibitor caspase-3 (z-DEVD-FMK) can effectively transported brain after systemic administration incorporating brain-targeted nanoparticles (NPs). Chitosan NPs were loaded with then functionalized conjugating...

10.1038/jcbfm.2014.220 article EN Journal of Cerebral Blood Flow & Metabolism 2014-12-10

In this study, it was aimed to investigate characteristics and intracellular delivery of two different-sized PLGA nanoparticles in ouzo region by considering number nanoparticles. To determine the effect formulation parameters on average particle size, Dil labeled were prepared using a three-factor, two-level full factorial statistical experimental design. PLGA230 (230.8 ± 4.32 nm) PLGA160 (157.9 6.16 obtained altering polymer amount based design results characterized. Same per cell applied...

10.1080/21691401.2016.1276924 article EN Artificial Cells Nanomedicine and Biotechnology 2017-01-13

The blood-brain barrier (BBB) is the major problem for treatment of central nervous system diseases. A previous study from our group showed that brain-targeted chitosan nanoparticles-loaded with large peptide moieties can rapidly cross and provide neuroprotection. present aims to determine efficacy nanoparticles' uptake by human BBB cerebral microvessel endothelial cells (hCMECs) investigate underlying mechanisms enhanced cellular entry. Fluorescently labelled nanoparticles either conjugated...

10.1080/02652048.2017.1375039 article EN Journal of Microencapsulation 2017-09-01

Nano drug co-delivery system is a popular strategy for combined application of two or more anticancer and/or synergistic drugs. Synergistic effects nonsteroidal anti-inflammatory drugs and anti-cancer in cancer treatment are shown the literature. This study aimed to screen understand critical formulation process parameters preparation flurbiprofen paclitaxel co-loaded nanoparticles develop an nano system. With this aim, were determined using Plackett–Burman experimental design (DoE)....

10.26650/istanbuljpharm.2019.19036 article EN cc-by-sa Istanbul Journal of Pharmacy 2019-10-08
Coming Soon ...